HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma
暂无分享,去创建一个
Ping Zhu | Ning Wen | Jing Xu | Yang Zhang | Li Wang | Jin-Liang Xing | Yang Zhang | P. Zhu | Xiang-min Yang | Zhi-Nan Chen | Jian-Li Jiang | H. Yao | Qing Zhang | Hui-Yun Xu | Fei Song | Xiang-Min Yang | Li Mi | Rong Tian | Qiang Feng | Jian-Li Jiang | Zhi-Nan Chen | Li Wang | Hui Yao | Lisyany Mi | Q. Feng | Ning Wen | R. Tian | Fei Song | J. Xing | Qing Zhang | Hui Xu | Jing Xu
[1] K. Dou,et al. HAb18G/CD147 enhances the secretion of matrix metalloproteinases (MMP) via cGMP/NO-sensitive capacitative calcium entry (CCE) and accordingly attenuates adhesion ability of fibroblasts. , 2005, European journal of cell biology.
[2] H. Chan,et al. The Involvement of HAb18G/CD147 in Regulation of Store-operated Calcium Entry and Metastasis of Human Hepatoma Cells* , 2001, The Journal of Biological Chemistry.
[3] T. Kanekura,et al. Basigin (cd147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts , 2002, International journal of cancer.
[4] K. Nabeshima,et al. Enhanced expression of a tumor‐cell‐derived collagenase‐stimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancers , 1993, International journal of cancer.
[5] M. Yu,et al. HAb18G/CD147-mediated calcium mobilization and hepatoma metastasis require both C-terminal and N-terminal domains , 2004, Cellular and Molecular Life Sciences CMLS.
[6] Y. Okada,et al. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas , 2000, International journal of cancer.
[7] J. Dancey,et al. Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[9] K. Hess,et al. Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Xu,et al. CD147, MMP-2, MMP-9 and MVD-CD34 are significant predictors of recurrence after liver transplantation in hepatocellular carcinoma patients , 2006, Cancer biology & therapy.
[11] Y. Li,et al. Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98. , 2004, World journal of gastroenterology.
[12] Young-Chae Chang,et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] Xiwu Chen,et al. Increased plasma MMP9 in integrin α1‐null mice enhances lung metastasis of colon carcinoma cells , 2005, International journal of cancer.
[14] K. Ohshima,et al. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T‐cell lymphomas , 2004, The Journal of pathology.
[15] Jing Xu,et al. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: clinical phase I/II trials. , 2006, International journal of radiation oncology, biology, physics.
[16] T. Hoang‐Xuan,et al. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. , 2005, Biochimie.
[17] W. Jin,et al. Extracellular Matrix Metalloproteinase Inducer (CD147) Confers Resistance of Breast Cancer Cells to Anoikis through Inhibition of Bim* , 2006, Journal of Biological Chemistry.
[18] Min Zhang,et al. Biodistribution and localization of iodine-131 labeled metuximab in patients with hepatocellular carcinoma , 2006, Cancer Biology & Therapy.
[19] C. Gilles,et al. Tumor Collagenase Stimulatory Factor (TCSF) Expression and Localization in Human Lung and Breast Cancers , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[20] Maria Pavlaki,et al. Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials , 2003, Cancer and Metastasis Reviews.
[21] A. Rosemurgy,et al. Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] S. Ye,et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis , 1999, British Journal of Cancer.
[23] Yi Tang,et al. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. , 2004, Molecular cancer research : MCR.
[24] J. Xu,et al. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[25] Y. Liu. [Localization of hepatocellular carcinoma with monoclonal antibodies]. , 1991, Zhonghua yi xue za zhi.
[26] H. Moses,et al. Tumor-stroma interactions. , 2005, Current opinion in genetics & development.
[27] Ping Zhu,et al. A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation , 2007, Hepatology.
[28] S. Zucker,et al. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.
[29] B. Toole. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. , 2003, Current topics in developmental biology.
[30] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.